Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

Vizz is the first and only aceclidine-based eye drop to improve near vision in adults with presbyopia. Vizz contracts the ...

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours at a time.

The FDA has approved VIZZ eye drops (LENZ Therapeutics, Inc.) for the treatment of presbyopia, the gradual loss of near ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

The US Food and Drug Administration has approved Vizz eye drops. These drops improve near vision for adults over 40. Lenz ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

Our data shows VIZZ (aceclidine 1.44%) received FDA approval in July 2025, positioning the once-daily, preservative-free ...

The Food and Drug Administration has approved Vizz (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in ...

Quantumpharm Inc., known as Xtalpi Inc., announced receiving $51 million up front from a potential $5.99 billion deal with ...

Location, location, location. While location is as important in manufacturing as it is in buying a home, it could become even ...